MOLECULAR BIOLOGY AND GENETICS OF CANCER PROGRAM The Molecular Biology and Genetics of Cancer Program integrates fundamental studies in the control of gene transcription with the genetic events and the molecular mechanisms underlying the most common types of hematological malignancies and solid tumors. An integral part of the KCC since 1991, this program focuses on gene discovery and gene function analyses. The long-term objective of this program is to exploit the translational potential of these studies for cancer diagnosis, prevention and therapy. The Molecular Biology and Genetics of Cancer Program is composed of 13 faculty members representing 5 different departments (including the Lankenau Institute for Medical Research). Several faculty members (Drs. Lisanti, McMahon, Nevalainen, O'Brien, Pascal, and Gilmour) are new recruits while most program members have been active in the KCC for many years. Program members are supported by NCI ($2.6 million) and other peer-reviewed grants ($9.8 million total peer-reviewed). They have 373 cancer-related publications, 13.5% of which are intra-programmatic and 19% are inter-programmatic. All faculty (except Drs. Gilmour and O'Brien) are housed in the Bluemle Life Sciences Building or Jefferson Alumni Hall. The program has 15-20 graduate students and more than 50 postdoctoral fellows. The program has monthly meetings to foster intra- and inter-programmatic interactions and to enhance its translational focus.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-13
Application #
8378857
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
13
Fiscal Year
2012
Total Cost
$29,624
Indirect Cost
$10,380
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications